VDAC1 and amyotrophic lateral sclerosis: Moreover, both pharmacological blockade and genetic deletion of mPTP and VDAC1 in an in vitro model of ALS reduced cytoplasmic accumulation of mtDNA and cGAS–STING activation [51].